Brief: Black Diamond Therapeutics Says Cash Runway Extended Into Q3 2024
11/05/2022 22:57
May 11 (Reuters) - Black Diamond Therapeutics Inc BDTX.O :
* FINANCIAL POSITION STRENGTHENED AND CASH RUNWAY EXTENDED
INTO
THIRD QUARTER OF 2024
* QTRLY LOSS PER SHARE $0.70
* Q1 EARNINGS PER SHARE VIEW $-0.75 -- REFINITIV IBES DATA
Source text for Eikon: [https://bit.ly/3MjtSTO]
Further company coverage: BDTX.O
((Reuters.Briefs@thomsonreuters.com;))